Literature DB >> 16675194

Prevention of the interaction between HVEM, herpes virus entry mediator, and gD, HSV envelope protein, by a Keggin polyoxotungstate, PM-19.

Katsuaki Dan1, Toshihiro Yamase.   

Abstract

One of the Keggin-type heteropolyoxotungstates (K7[PTi2W10O40]6H2O:PM-19) is a potent inhibitor of the replication of herpes simplex virus (HSV) both standard strain 169 and the thymidine kinase-defective strain YS-4C-1 in vitro and in vivo. HSV envelope protein, gD, is necessary for virus entry into the cells. Some cellular molecules, such as HVEM, were reported to act as cofactors during the viral entry step. We determined whether PM-19 prevents these interactions between HSV-gD and HVEM. These activities were investigated using the Ciphergen and BIACORE system. Using a protein chip, many kinds of gD-specific binding proteins were captured, but these proteins could not be identified. Several proteins in these gD-binding proteins were inhibited its interaction with gD due to the presence of PM-19. Using the BIACORE system, the affinity of PM-19 to gD was low, because PM-19 has no direct inactivation activity against the virion. The specific binding of HVEM to the gD was shown as KD of 1.1e-9. The affinity of PM-19 for HVEM was high (KD:2e-9). To determine the competitive binding, the PM-19 (10 microg/ml) and several concentrations of HVEM solution mixtures were injected over the gD-fixed sensor surface. Each binding signal was stable in the range of approximately 270-300 RU. In the case of the addition of PM-19 to HVEM solution, the binding signals were elevated by PM-19 dose dependently. These results suggest that the bindings of PM-19 to gD are not disturbed by the presence of HVEM. PM-19 prevents the interaction between HVEM and gD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16675194     DOI: 10.1016/j.biopha.2006.02.005

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  A Novel Application of Ti-Substituted Polyoxometalates: Anti-Inflammatory Activity in OVA-Induced Asthma Murine Model.

Authors:  Dong Li; Xiuzhu Gao; Jingmin Gu; Yuan Tian; Yaqing Liu; Zheng Jin; Dongmei Yan; Ya-Guang Chen; Xun Zhu
Journal:  Bioinorg Chem Appl       Date:  2016-06-29       Impact factor: 7.778

2.  In vitro anti-hepatitis B and SARS virus activities of a titanium-substituted-heteropolytungstate.

Authors:  Yan-fei Qi; Hong Zhang; Juan Wang; Yanfang Jiang; Jinhua Li; Ye Yuan; Shiyao Zhang; Kun Xu; Yangguang Li; Juan Li; Junqi Niu; Enbo Wang
Journal:  Antiviral Res       Date:  2011-11-23       Impact factor: 5.970

3.  New composition of tungsten has a broad range of antiviral activity.

Authors:  Hranush Avagyan; Anaida Mirzoyan; Ferdinand Mirzoyan; Roza Izmailyan; Sona Hakobyan; Henry Voskanyan; Zara Semerjyan; Aida Avetisyan; Hranush Arzumanyan; Elena Karalova; Liana Abroyan; Lina Hakobyan; Nane Bayramyan; Nazeli Gevorgyan; Alexander Karalyan; Zaven Karalyan
Journal:  Antivir Chem Chemother       Date:  2022 Jan-Dec

Review 4.  Promising application of polyoxometalates in the treatment of cancer, infectious diseases and Alzheimer's disease.

Authors:  Xuechen Wang; Shengnan Wei; Chao Zhao; Xin Li; Jin Jin; Xuening Shi; Zhenyue Su; Juan Li; Juan Wang
Journal:  J Biol Inorg Chem       Date:  2022-06-17       Impact factor: 3.862

5.  Cytotoxicity and enzyme inhibition studies of polyoxometalates and their chitosan nanoassemblies.

Authors:  Hamid Saeed Shah; Rami Al-Oweini; Ali Haider; Ulrich Kortz; Jamshed Iqbal
Journal:  Toxicol Rep       Date:  2014-06-06

6.  Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Keggin Polyoxometalate.

Authors:  Xiaoli Wang; Jiao Wang; Wenmei Zhang; Boye Li; Ying Zhu; Qin Hu; Yishu Yang; Xiaoguang Zhang; Hong Yan; Yi Zeng
Journal:  Viruses       Date:  2018-05-16       Impact factor: 5.048

Review 7.  Polyoxometalates active against tumors, viruses, and bacteria.

Authors:  Toshihiro Yamase
Journal:  Prog Mol Subcell Biol       Date:  2013
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.